DOSIERFORMEN FÜR ARZNEIMITTEL

Patent europeic · EP3079667 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3079667
Numer da la dumonda
EP14819084
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-12-2014
Publitgà
19-10-2016
Concedì
26-06-2019
La protecziun finescha il pli tard
10-12-2034
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 9/16 (2006.01)
A61K 9/48 (2006.01)
A61K 31/506 (2006.01)
Prioritad
US 201361915606 P 13.12.2013
Dumonda PCT
PCT/IB2014/066820 11.12.2014
Publicaziun PCT
WO2015/087283 18.06.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 08-01-2025

    Midada

    Published in Swissreg on 08.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 10-01-2023

    Midada

    Published in Swissreg on 10.01.2023

  5. 26-06-2019

    Concedì

    Published in Swissreg on 26.06.2019

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

RIBEIRO, Suzie

4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.